Third Arc Bio Inc., a clinical stage biotech company developing novel multifunctional antibodies for a range of oncology and immunology & inflammation (I&I) indications, today announced the first ...

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that the Safety Review Committee (SRC) ...

TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, has been recognized by CIOReview as a Top ...

Rikers Island correction captains and officers revived a man who had overdosed on drugs, and a detainee with a long record of ...

Medical Industry Awards 2025 The Prestigious A' Medical Devices and Medical Equipment Design Award Extends Last Entry Period Until March 30 ...

After responding to call in Mea Shearim, paramedics returned to vehicle to find graffiti; Magen David Adom head decries ...

Medicaid serves lower-income adults, children, pregnant women, and people with disabilities, as well as dually-enrolled ...

“The KickStart Grant Awards help de-risk these technologies by establishing a collaboration agreement between the startup ...

"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.

Golden Helix, a global leader in bioinformatics solutions for Next-Generation Sequencing (NGS) and precision medicine, is proud to announce a multi-year ...

Q4 2024 Earnings Call Transcript March 7, 2025 Operator: Good morning, and welcome to the Molecular Partners Fourth Quarter ...